文献速递肝病

原发性硬化性胆管炎患者胆汁来源类器官再现其炎症免疫特征

Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile.
PubMed 文献 · Hepatology · 2019-03-13

研究从接受内镜逆行胰胆管造影的原发性硬化性胆管炎(PSC)患者胆汁中分离干细胞,长期培养为三维类器官,其表达胆管细胞标志物,RNA测序发现39个基因表达差异,包括免疫相关基因HLA-DMα和CCL20,白介素17A或肿瘤坏死因子α刺激后分泌CCL20等促炎介质增加。

要点

  • 胆汁来源类器官(BDOs)可长期培养并表达胆管细胞标志物。
  • PSC患者BDOs与对照相比有39个基因表达差异,含免疫相关基因。
  • 白介素17A或肿瘤坏死因子α刺激使BDOs分泌CCL20等促炎介质显著增加。

核心结论

  • 胆汁可作为胆管样细胞来源,长期维持为三维类器官,保留胆管病特征,包括对炎症刺激分泌趋化因子并传播免疫反应表型的能力,BDOs为胆管病尤其是PSC的发病机制和治疗研究提供平台。

研究设计与样本

  • 从接受内镜逆行胰胆管造影的PSC患者胆汁中分离干细胞,体外长期培养为三维类器官,并与非PSC对照比较。

主要发现

  • BDOs表达γ-谷氨酰转移酶、细胞角蛋白19、上皮细胞黏附分子、囊性纤维化跨膜传导调节因子和阴离子交换器2等胆管细胞标志物。
  • RNA测序分析发现PSC患者类器官与非PSC对照相比有39个基因表达差异,包括HLA-DMα链和CCL20。
  • BDOs与白介素17A或肿瘤坏死因子α孵育后,CCL20等促炎介质分泌显著增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary sclerosing cholangitis (PSC) is a heterogeneous and progressive fibroinflammatory cholangiopathy with no known etiology or effective treatment. Studies of PSC are limited due to difficulty in accessing the cholangiocyte, the small percentage of these cells in the liver, instability of in vitro culture systems, and reliance on samples from end-stage disease. Here, we demonstrate that stem cells can be isolated from the bile of PSC patients undergoing endoscopic retrograde cholangiopancreatography earlier in their clinical course and maintained long term in vitro as three-dimensional (3D) organoids that express a biliary genetic phenotype. Additionally, bile-derived organoids (BDOs) can be biobanked and samples obtained longitudinally over the course of the disease. These BDOs express known cholangiocyte markers including gamma glutamyl transferase, cytokeratin 19, epithelial cellular adhesion molecule, cystic fibrosis transmembrane conductance regulator, and anion exchanger 2. RNA sequence analysis identified 39 genes whose expression differed in organoids from PSC patients compared to non-PSC controls, including human leukocyte antigen DM alpha chain and chemokine (C-C motif) ligand 20 (CCL20), immune-related genes previously described in genome-wide association studies of PSC. Incubation of these BDOs with interleukin 17A or tumor necrosis factor alpha led to an immune-reactive phenotype with a significant increase in secretion of proinflammatory mediators, including CCL20, a T-cell chemoattractant. Conclusion: This study demonstrates that bile can be used as a source of biliary-like cells that can be maintained long term in vitro as 3D organoids; these BDOs retain features of cholangiopathies, including the ability to react to inflammatory stimuli by secreting chemokines and propagating an immune-reactive phenotype reflective of the pathogenesis of these diseases; thus, BDOs represent a platform for the study of the pathogenesis and therapy of cholangiopathies, particularly PSC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Soroka CJ, Assis DN, Alrabadi LS, et al. Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile. Hepatology. 2019. PMID: 30561836. doi:10.1002/hep.30470

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。